| Not Yet Recruiting | 1% Clascoterone Cream for the Treatment Acne Vulgaris NCT07457294 | Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd. | Phase 3 |
| Not Yet Recruiting | Comparative Effectiveness of Clindamycin-Retinoid, Clindamycin-Retinoid-Dexamethasone, and 10% SM-hUCMSC Secre NCT07504822 | Yohanes Firmansyah, dr, MH, MM | Phase 1 / Phase 2 |
| Recruiting | Skin Inflammation in Perimenopause: A Probiotic Intervention Proof of Concept Trial NCT07341087 | King's College London | N/A |
| Not Yet Recruiting | Topical 5% Spironolactone Gel Versus 0.1% Adapalene Gel for Acne Vulgaris: A Randomized Split-Face Study NCT07473895 | Assiut University | Phase 2 |
| Not Yet Recruiting | Evaluation of Topical Dutasteride as a Potential New Therapy for Facial Acne Vulgaris Versus the Triple Combin NCT07421804 | Assiut University | N/A |
| Not Yet Recruiting | Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo NCT07524946 | Bausch Health Americas, Inc. | Phase 4 |
| Not Yet Recruiting | A Study to Evaluate Efficacy and Safety of HB0043 in Aadult Patients With Moderate to Severe Acne Vulgaris. NCT07449156 | Shanghai Huaota Biopharmaceutical Co., Ltd. | Phase 1 / Phase 2 |
| Recruiting | Efficacy of 0.5% Topical Timolol Eye Drops in the Treatment of Post-Inflammatory Erythema Following Acne Vulga NCT07474883 | Pham Ngoc Thach University of Medicine | EARLY_Phase 1 |
| Not Yet Recruiting | Study of New Antiandrogenic Progestogen + Low-dose Estrogen for Moderate Acne Vulgaris NCT06905210 | Eurofarma Laboratorios S.A. | Phase 3 |
| Not Yet Recruiting | Metronidazole 2% Gel Versus Clindamycin 1% Gel for Moderate Acne Vulgaris NCT07392047 | Jinnah Postgraduate Medical Centre | Phase 4 |
| Not Yet Recruiting | Safety, Efficacy and Pharmacokinetic Characteristics of KR230109 Cream in Facial Acne Vulgaris NCT07345390 | Jiangxi Kvvit Pharmaceutical Co., Ltd. | Phase 2 |
| Completed | Clinical Insights Into Dextrose Phonophoresis on Mild to Moderate Acne Vulgaris NCT07169890 | MTI University | N/A |
| Not Yet Recruiting | Evaluation of Serum Ceramides C16, C24, and Sphingosine-1-Phosphate (S1P) in Patients With Acne Vulgaris NCT07250880 | Sohag University | — |
| Completed | A Clinical In-Use Evaluation to Assess the Tolerability and Efficacy of a Moisturizer on Acne Prone Skin NCT07224633 | Kenvue Brands LLC | N/A |
| Active Not Recruiting | Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Triple Combination Gel in Canadian Patients With Acne V NCT07205107 | Bausch Health Americas, Inc. | — |
| Recruiting | A Study to Compare the Efficacy, Safety and Pharmacokinetics of Trifarotene 50 mcg/g Cream in Chinese Subjects NCT07186413 | Galderma R&D | Phase 3 |
| Completed | A Study Comparing Tretinoin Gel Microsphere, 0.04% and RETIN-A MICRO ® Gel Microsphere, 0.04% in the Treatment NCT07469228 | Sun Pharmaceutical Industries, Inc. | Phase 1 |
| Not Yet Recruiting | Correlation Between Acne Vulgaris and Lipid Profile Among Young Adults in Sohag Governorate NCT07062081 | Sohag University | N/A |
| Recruiting | Cold Atmospheric Plasma for Moderate-to-severe Acne Vulgaris Study NCT07056673 | Shenyang Medical College | N/A |
| Recruiting | Efficacy and Safety of Adapalene Gel and Hyaluronic Acid Versus Adapalene Gel Alone in Mild to Moderate Acne V NCT07102186 | Badr University | Phase 4 |
| Recruiting | Clinical Trial to Compare Oral Isotretinoin to Standard of Care in Moderate Acne Skin of Color Patients NCT06447480 | Centre Hospitalier Universitaire de Nice | Phase 3 |
| Enrolling By Invitation | Randomized, Triple-Blind, Placebo-Controlled Trial of Topical Dapsone Gel in Patients With Acne Vulgaris NCT07244887 | Oya Helin Dundar | Phase 4 |
| Recruiting | Efficacy of Dihydroartemisinin for Treating Acne Vulgaris NCT07007078 | Shanghai Zhongshan Hospital | EARLY_Phase 1 |
| Not Yet Recruiting | Dry Eye Disease With Isotretinoin ISOTRETINOIN NCT06725290 | Cairo University | — |
| Not Yet Recruiting | Excimer Light Versus Blue Light in Acne NCT06725303 | Cairo University | N/A |
| Not Yet Recruiting | The Relationship Between Microbioma Balance and Acne Vulgaris as a New Acne Treatment NCT06925386 | Universitas Padjadjaran | Phase 2 |
| Not Yet Recruiting | Serum CXCL10 and CRP Levels in Patients With Acne Vulgaris in Correlation With Disease Severity NCT06869109 | Assiut University | — |
| Not Yet Recruiting | The Effectiveness and Safety of Cleanser Containing Triethyl Citrate, Pyruvic Acid, Combination Cream Containi NCT06775314 | Dr.dr.Irma Bernadette, SpKK (K) | Phase 3 |
| Completed | Efficacy of Oral Metformin vs Oral Doxycycline in Treating Acne Vulgaris NCT07357337 | Ghurki Trust and Teaching Hospital | Phase 4 |
| Completed | A Clinical Evaluation of Marula-Derived Ceramide Cream on Skin Barrier Function Enhancement NCT07066150 | Shanghai Chicmax Cosmetic Co., Ltd. | N/A |
| Recruiting | Weekly Isotretinoin vs Tetracycline for Moderate Acne NCT06225570 | Medical University of South Carolina | EARLY_Phase 1 |
| Recruiting | Assessment of Serum Catestatin Level in Acne Vulgaris Patients NCT07054398 | Aswan University | N/A |
| Active Not Recruiting | A Long-term Safety and Efficacy Study of N-Acetyl-GED-0507-34-LEVO Gel 5%, in Subjects With Acne Vulgaris (GED NCT07389109 | PPM Services S.A. | Phase 3 |
| Completed | Efficacy, Safety Profile, and Post-Acne Sequelae of 0.025% Retinoic Acid Cream vs. 0.1% Adapalene Cream in Mil NCT07015931 | Indonesia University | Phase 1 / Phase 2 |
| Completed | A Study to Learn About the Study Medicine Called PF-07905428 in Healthy Participants and Participants With Acn NCT06671834 | Pfizer | Phase 1 |
| Active Not Recruiting | A Study to Assess Efficacy and Safety of N-Acetyl-GED-0507-34-LEVO Gel 5%, in Patients With Acne Vulgaris (GED NCT07384195 | PPM Services S.A. | Phase 3 |
| Active Not Recruiting | A Study to Assess Efficacy and Safety of N-Acetyl-GED-0507-34-LEVO Gel 5% in Patients With Acne Vulgaris (GEDA NCT07384208 | PPM Services S.A. | Phase 3 |
| Active Not Recruiting | Effectiveness and Safety of Zingiber Officinale Transdermal Patch for Acne Vulgaris; Study of Interleukin 1 an NCT06787222 | Hasanuddin University | Phase 2 / Phase 3 |
| Completed | Auricular Acupressure Combined With Adapalene for the Treatment of Acne Vulgaris NCT07348978 | University of Medicine and Pharmacy at Ho Chi Minh City | N/A |
| Not Yet Recruiting | Fractional CO2 Laser Delivery of Topical Insulin Versus Platelet Rich Plasma in Treatment of Atrophic Post Acn NCT06590909 | Assiut University | N/A |
| Completed | Probiotic Intervention and Its Influence on Serum Leucine-Rich Alpha-2 Glycoprotein 1 Levels in Acne Vulgaris NCT07277075 | Benha University | — |
| Completed | Pharmacokinetics, Safety and Tolerability of Clascoterone Cream 1% in Healthy Chinese Adult Subjects NCT06454708 | Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd. | Phase 1 |
| Recruiting | Clascoterone for Steroid-related Acne Vulgaris in Transgender Male Patients Receiving Masculinizing Hormone Th NCT05891795 | Stanford University | Phase 1 / Phase 2 |
| Active Not Recruiting | A Study to Assess Sebaceous Gland Changes and Constituents of Sebum (Skin Oil) Induced by Clascoterone 1% Crea NCT06425900 | Sun Pharmaceutical Industries Limited | Phase 4 |
| Completed | A Study Comparing Trifarotene Cream 0.005% to AKLIEF® CREAM (US REFERENCE LISTED DRUG), AKLIEF™ CREAM (CANADIA NCT06733402 | Sun Pharmaceutical Industries, Inc. | Phase 1 |
| Not Yet Recruiting | Association of Acne Vulgaris With Oral Hygiene and Gingivitis NCT06237387 | Erzincan University | — |
| Not Yet Recruiting | Serum Intercellular Adhesion Molecule -1 in Acne Vulgaris Patients : Effect of Montelukast NCT06340984 | South Valley University | Phase 3 |
| Recruiting | Efficacy and Safety of Clascoterone Cream 1% in Facial Acne Vulgaris NCT06403501 | Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd. | Phase 3 |
| Completed | A Study Comparing Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2% (Taro Pha NCT06673641 | Sun Pharmaceutical Industries, Inc. | Phase 1 |
| Completed | A Study to Assess the Safety and Efficacy of a Sunscreen on Acne-Prone Skin With Inflammatory and Non-Inflamma NCT06544889 | JNTL Consumer Health (Brasil) LTDA | N/A |
| Completed | A Study to Evaluate the Reduction in Sebum (Skin Oil) Induced by Clascoterone Cream 1% in Acne Patients NCT06415279 | Sun Pharmaceutical Industries Limited | Phase 4 |
| Recruiting | Vitamin D Supplementation in Acne NCT06141330 | HITEC-Institute of Medical Sciences | N/A |
| Completed | Correlation Between Depression Scores and Serum NF-ĸB/NLRP3 Axis, Biotinidase, and HMGB After Treatment With I NCT06242288 | Mostafa Bahaa | Phase 3 |
| Unknown | Assessment of Serum and Tissue Tryptase Levels in Acne Vulgaris Patients NCT06158061 | Sohag University | N/A |
| Recruiting | Intense Pulsed Light (IPL) Medical Device as Treatment for Patient Suffering From Skin Disorder NCT06655129 | Eurofeedback | N/A |
| Unknown | Clinical Workflow Optimization Using Artificial Intelligence for Dermatological Conditions NCT06263413 | AI Labs Group S.L | — |
| Completed | Low Level Laser Versus Polarized Light in the Treatment of Acne Vulgaris NCT06867276 | Cairo University | N/A |
| Unknown | Platelet-rich Plasma With Topical Retinoids Versus Topical Retinoids Alone in Acne Vulgaris NCT06281782 | Assiut University | N/A |
| Unknown | Efficacy of Manuka Honey Nano-Formulation in the Treatment of Acne Vulgaris NCT06175819 | Al-Azhar University | N/A |
| Completed | The Impact of Untreated Depression and Anxiety Among Patients With Skin Diseases in Jeddah, Saudi Arabia. NCT07046039 | King Abdulaziz University | — |
| Completed | DMT310-009 Topical in the Treatment of Acne Vulgaris NCT06090721 | Dermata Therapeutics | Phase 3 |
| Completed | A Study to Evaluate the Impact of Clascoterone 1% Cream on Skin Barrier Properties in Acne Prone Patients NCT06415292 | Sun Pharmaceutical Industries Limited | Phase 4 |
| Completed | A Study Assessing the Efficacy and Safety of Combined Use of Clascoterone 1% Cream and Duac Gel (Benzoyl Perox NCT06336629 | Sun Pharmaceutical Industries Limited | Phase 4 |
| Completed | A Study Assessing the Efficacy of Combined Use of Clascoterone 1% Cream and Adapalene 0.3% for the Treatment o NCT06336603 | Sun Pharmaceutical Industries Limited | Phase 4 |
| Unknown | Assessment of the Effects of Silk Pillowcases on Acne Prone Skin NCT06142487 | Integrative Skin Science and Research | N/A |
| Recruiting | Profiles Analysis of Genome Wide Association Study (GWAS) in Acne Vulgaris in Indonesia. NCT06501560 | Dr.dr.Irma Bernadette, SpKK (K) | N/A |
| Completed | The Impact of Probiotics on Skin Hydration in Youth with Mild Acne NCT05755256 | Lallemand Health Solutions | Phase 2 |
| Completed | Retinoic Acid Therapy and Regulation of Salivary and Serum IL-1β, IL-8 and MCP-1 Levels NCT06879795 | Medipol University | — |
| Completed | A Study Evaluating the Efficacy and Safety of Clascoterone Cream 1% in Skin of Color Patients With Acne NCT06415305 | Sun Pharmaceutical Industries Limited | Phase 4 |
| Unknown | Comparison of Quality of Life in Moderate Acne Vulgaris Patients Based on Acne-QoL-INA Using Standard Therapy NCT06181838 | Indonesia University | N/A |
| Unknown | Measurement of Serum microRNA in Acne Vulgaris Patient NCT05885217 | South Valley University | — |
| Unknown | Toxicity and Efficacy Evaluation of Topical Minoxidil in Acne Vulgaris NCT06108193 | Chang Gung Memorial Hospital | Phase 1 / Phase 2 |
| Completed | The Effects of Oral Probiotics and Herbal Supplementation on the Gut Microbiome and Sebum Excretion Rate in No NCT05919810 | Integrative Skin Science and Research | N/A |
| Unknown | Effect of New Topical Preparation for Treatment of Acne Vulgaris NCT05899699 | Mansoura University | Phase 2 |
| Completed | Effect of Systemic Isotretinoin on Serum Irisin Level in Acne Vulgaris Patients NCT05869188 | South Valley University | N/A |
| Unknown | Evaluation of the Role of Latent Toxoplasmosis in Female Patients With Active Acne Vulgaris NCT05783778 | Sohag University | N/A |
| Completed | Effectiveness of Standard Therapy of Acne Vulgaris NCT05982613 | Indonesia University | — |
| Withdrawn | The Use of Teledermatology in the Treatment of Patients With Severe Acne on Isotretinoin NCT03707236 | Massachusetts General Hospital | N/A |
| Unknown | Comparative Study of Metformin Versus Doxycycline in Moderate to Severe Adult Acne Vulgaris Patients. NCT06252194 | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Phase 2 |
| Completed | Anti-microbial Role of Non-antibiotic Agents Against Cutibacterium Acnes in Patients With Acne Vulgaris NCT06179056 | Zagazig University | — |
| Completed | A Study Comparing Trifarotene Cream 0.005% to AKLIEF® Cream in the Treatment of Acne Vulgaris NCT06063473 | Sun Pharmaceutical Industries, Inc. | Phase 1 |
| Unknown | Safety and Efficacy Evaluation of the Mosaic Ultra Device NCT06117293 | CynosureLutronic | N/A |
| Unknown | The Efficacy and Safety of Topical Vitamin D and Supplementation In Acne Vulgaris The Study of VDR, IL-1β, IL- NCT05758259 | Indonesia University | Phase 4 |
| Unknown | Self-Administered Intralesional Injections for Acne NCT06186596 | ACOM Labs | N/A |
| Completed | Evaluation of Efficacy and Tolerance of Crystal Peel in the Treatment of Adults Presenting Facial Mild Acne NCT05821296 | Dermosciences France | N/A |
| Unknown | Microbiome Comparison Profile of Normal Skin and Acne Vulgaris Patients NCT05838534 | Dr.dr.Irma Bernadette, SpKK (K) | — |
| Unknown | Comparison Between Isotretinoin, Silymarin and Both in the Treatment of Acne Vulgaris NCT05666765 | Tanta University | Phase 4 |
| Completed | Autologous Plasma Gel Injection Versus Polydioxanone Cog Threads Insertion for the Treatment of Atrophic Post- NCT06580691 | Sameh Sarsik | N/A |
| Unknown | Impact of Isotretinoin in Different Doses on Quality of Life NCT05316675 | Assiut University | Phase 4 |
| Completed | Intralesional Injections of Triamcinolone for Acne Vulgaris NCT06170593 | ACOM Labs | N/A |
| Completed | Evaluation of Safety and Performance of Ialuxid Gel in Treatment of Acne Vulgaris, and Folliculitis NCT05345093 | BMG Pharma | N/A |
| Completed | Study Comparing Trifarotene Cream, 0.005% To AKLIEF ® (Trifarotene 0.005% Cream) In The Treatment Of Acne Vulg NCT05550337 | Teva Pharmaceuticals USA | Phase 3 |
| Unknown | The Effects of Systemic Isotretinoin Treatment on Adrenal Steroid and Sex Hormones Level in Severe Acne Vulgar NCT05903716 | Marmara University | — |
| Unknown | Topical Metformin Emulgel VS Salicylic Acid Peeling in Treatment of Acne Vulgaris NCT05536193 | Assiut University | Phase 4 |
| Unknown | DAPSONE GEL7.5%Versus Trichloroacetic Acid 20% ON ACNE VULGARIS NCT05296460 | Assiut University | Phase 4 |
| Unknown | Effectivity and Safety of Combination Cream of Salicylic Acid, Aqua Posae Filiformis, Niacinamide, Lipohydroxy NCT05497323 | Dr.dr.Irma Bernadette, SpKK (K) | Phase 1 |
| Completed | Comparison of the Efficacy of Clindamycin Phosphate 1% Gel Versus Once-daily Dapsone 5% Gel in the Treatment o NCT05926869 | Jinnah Postgraduate Medical Centre | Phase 2 |
| Unknown | A Study of a Laser for the Treatment of Acne Vulgaris NCT05430464 | Cutera Inc. | N/A |
| Active Not Recruiting | A Post Market Device Study for the Treatment of Acne NCT06469398 | Cutera Inc. | N/A |
| Unknown | Assessment of Serum Asprosin Level in Male Patients With Acne Vulgaris NCT05471388 | Sohag University | N/A |
| Completed | Efficacy of 25% Trichloroacetic Acid Peel Versus 30% Salicylic Acid Peel in Mild to Moderate Acne Vulgaris NCT05712837 | Combined Military Hospital Abbottabad | N/A |
| Completed | Impact of COVID-19 Vaccination on Serum 25-hydroxyvitamin D Level NCT05398939 | National Taiwan University Hospital | — |
| Unknown | A Botanical Skin Care Regimen on Mild to Moderate Acne and the Microbiome NCT05271487 | Integrative Skin Science and Research | N/A |
| Completed | Combined Low-Dose Isotretenion and Long-Pulsed 1064 ND-YAG Laser in the Treatment of Acne Erythema NCT05622253 | Zagazig University | N/A |
| Unknown | Almond Supplementation on Mild to Moderate Acne NCT05269641 | Integrative Skin Science and Research | N/A |
| Unknown | "A Comparative Clinical Evaluation of the Efficacy of Topical Adapalene, Benzoyl Peroxide Gel, Oral Lactobacil NCT05855629 | Treatment and Diagnostic Center of Private Enterprise "Asklepiy" | N/A |
| Completed | Study in Subjects to Evaluate the Safety, Tolerability and Pharmacokinetics of GT20029 NCT05428449 | Suzhou Kintor Pharmaceutical Inc, | Phase 1 |
| Completed | Study to Evaluate the Safety and Efficacy of ASC40 in Subjects With Moderate to Severe Acne Vulgaris NCT05104125 | Ascletis Pharmaceuticals Co., Ltd. | Phase 2 |
| Completed | C-Reactive Protein/Albumin Ratio and Acne Vulgaris NCT06004583 | Ataturk University | — |
| Completed | Serum TWEAK Levels in Acne Vulgaris NCT05684861 | South Valley University | Phase 2 |
| Completed | AkLief Evaluation in Acne-induced Post-Inflammatory Hyperpigmentation NCT05089708 | Galderma R&D | Phase 4 |
| Unknown | Effectivity and Safety of Combination of Spent Grain Wax, Argan Oil, Shea Butter and Saccharide Isomerate NCT05186246 | Dr.dr.Irma Bernadette, SpKK (K) | Phase 1 |
| Active Not Recruiting | Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Moderat NCT05080764 | Biofrontera Inc. | Phase 2 |
| Unknown | Oral Baidi Quzhi Granule Combined With Ju Ying Cream for Acne Vulgaris NCT05035979 | Shanghai Yueyang Integrated Medicine Hospital | Phase 3 |
| Completed | Investigation of the Effect of Oral Isotretinoin on Skin Thickness and Elasticity in Patients With Atrophic Ac NCT05413200 | Istanbul Training and Research Hospital | — |
| Completed | A Study of a Polymeric Surfactant Technology Cleanser in Sensitive Skin Participants NCT05094700 | Johnson & Johnson Consumer Inc. (J&JCI) | N/A |
| Completed | Comparing Efficacy of Azithromycin and Probiotics for Treatment of Acne Vulgaris NCT05629468 | Pak Emirates Military Hospital | Phase 3 |
| Unknown | Clinico-demographic Features of Patients With Acne Vulgaris NCT05061615 | Sohag University | — |
| Completed | Safety, Tolerability, and Immunogenicity of ORI-A-ce001 for the Treatment of Acne Vulgaris NCT05131373 | Sanofi Pasteur, a Sanofi Company | Phase 1 |
| Completed | To Evaluate the Efficacy and Safety of Minocycline Hydrochloride Foam in the Treatment of Moderate-to-severe A NCT04960930 | Cutia Therapeutics (Shanghai) Co., Ltd | Phase 3 |
| Unknown | Double-blinded, Vehicle Controlled Study to Evaluate Efficacy & Tolerance of Bakuchiol and Ethyl Linoleate on NCT05069272 | Ratan K. Chaudhuri | N/A |
| Unknown | Effect of Oral Isotretinoin on The Level of SerumYKL40 in Acne Vulgaris Patients NCT05218486 | Alshimaa Abbas Mohamed Ebrahim | Phase 4 |
| Completed | A Study of a Hydrocolloid Bandage on Pimples NCT05012735 | Johnson & Johnson Consumer Inc. (J&JCI) | Phase 1 |
| Completed | A Companion Treatment Study for Patients With Moderate to Severe Acne Vulgaris NCT04940767 | Edward Lain, MD | Phase 4 |
| Completed | Study to Compare the Safety and Efficacy of IDP-126 Gel to Epiduo® Forte Gel and Vehicle Gel NCT04892706 | Bausch Health Americas, Inc. | Phase 2 |
| Completed | Efficacy and Tolerability of Rehmannia Glutinosa Leaf Extract in the Treatment of Acne Vulgaris NCT04937374 | Vedic Lifesciences Pvt. Ltd. | N/A |
| Completed | Study of Trifarotene Cream to Assess Risk of a Trophic Acne Scar Formation NCT04856904 | Galderma R&D | Phase 4 |
| Active Not Recruiting | Laser Treatment of Moderate to Severe Acne Vulgaris NCT04466527 | Massachusetts General Hospital | N/A |
| Completed | A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Acne NCT04856917 | Vanda Pharmaceuticals | Phase 2 |
| Completed | Effectiveness of Zinc Supplementation With Topical Retinoids in Acne Vulgaris Patients NCT04899843 | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Phase 2 |
| Completed | Application of Poly-herbal Powder for Treating Acne Vulgaris NCT04949932 | Dr. Md. Shahab Uddin | N/A |
| Unknown | Vitamin A and Azithromycin for Acne Vulgaris NCT03090048 | Manchanda Medical Clinic | EARLY_Phase 1 |
| Unknown | Silymarin Cream Versus Salicylic Acid in Treatment of Acne Vulgaris NCT04490967 | Assiut University | Phase 4 |
| Completed | A Proof of Concept Study to Evaluate the Efficacy and Tolerability of Microneedling With SkinPen in Female and NCT05071274 | Crown Laboratories, Inc. | N/A |
| Completed | Patient-reported Outcomes for Sarecycline Effectiveness and Safety (PROSES) NCT04820673 | Almirall, S.A. | — |
| Completed | Sarecycline Truncal Acne Safety and Efficacy Response NCT05010538 | Angela Moore | — |
| Completed | Tazarotene 0.045% Lotion for Treating PIE and PIH in Subjects With Acne NCT05704114 | Dr. Emmy Graber | Phase 4 |
| Unknown | Full Spectrum Hemp Observational Study NCT04730414 | Charlotte's Web, Inc | — |
| Withdrawn | Skin Hydration in Persons With Acne After Dietary Supplementation With Botanical Antioxidants NCT04534140 | University of California, Los Angeles | N/A |
| Completed | Effectiveness and Tolerance of Effaclar Serum in Women With Mandibular Acne NCT05457621 | Cosmetique Active International | N/A |
| Completed | Pharmacokinetics and Safety of ALA in Acne Vulgaris NCT04044898 | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | Phase 1 |
| Completed | A Device Study for the Treatment of Acne NCT04695691 | Cutera Inc. | N/A |
| Completed | Measure the Serum Level of Homocysteine in Acne Patients Before and After Oral Isotretinoin. NCT05529888 | Aswan University | Phase 4 |
| Completed | Subantimicrobial Doxycycline in Acne NCT05399290 | Michigan State University | Phase 4 |
| Completed | Weekly Isotretinoin Therapy Study NCT04594759 | Medical University of South Carolina | Phase 1 / Phase 2 |
| Terminated | Acne Detection Software (AcneDect) NCT04060160 | University Hospital, Basel, Switzerland | — |
| Completed | Teledermatology vs. Face-to-Face Visits in the Follow-Up of Patients With Acne NCT04593004 | Insel Gruppe AG, University Hospital Bern | N/A |
| Completed | Clinical Evaluation of the Safety and Benefits of the Milesman 445 nm Blue Laser on Inflammatory Acne Lesions. NCT04698239 | Gaias Salud | N/A |
| Completed | Clinical Pharmacist Role in Adherence to Recommendations Among Isotretinoin Users NCT05839223 | Jordan University of Science and Technology | N/A |
| Completed | A Study Comparing Tretinoin Gel Microsphere, 0.1% and RETIN-A MICRO ® Gel Microsphere, 0.1% in the Treatment o NCT04883736 | Sun Pharmaceutical Industries, Inc. | EARLY_Phase 1 |
| Completed | A Study to Compare Efficacy and Safety of Trifarotene Cream When Used With an Oral Antibiotic for the Treatmen NCT04451330 | Galderma R&D | Phase 4 |
| Withdrawn | Clinical Endpoint Bioequivalence Study of Adapalene Gel 0.1% NCT04329403 | Aurobindo Pharma Ltd | Phase 3 |
| Withdrawn | Acne and Mood: Impact of Treatment on Depression, Anxiety, and Sexual Function NCT03921476 | Northwestern University | — |
| Completed | A Study Comparing Adapalene Gel 0.1% and to Differin Gel in the Treatment of Acne Vulgaris NCT04797793 | Sun Pharmaceutical Industries, Inc. | EARLY_Phase 1 |
| Unknown | Evaluate the Efficacy and Safety of Intense Pulsed Light Filters Combined With Oral Medication in the Treatmen NCT04433143 | Gang Wang | N/A |
| Unknown | Oral Probiotics on the Microbiome and Lipidome in Acne Vulgaris NCT04596748 | Integrative Skin Science and Research | N/A |
| Completed | Clinical Trial to Evaluate the Effect of a Probiotic in Acne NCT04570319 | Bionou Research, S.L. | N/A |
| Withdrawn | A Pilot Study to Explore the Role of Gut Flora in Acne NCT04214483 | ProgenaBiome | — |
| Unknown | Social Media Use of Acne Vulgaris Patients: Multicenter, Survey Work NCT04538703 | Istanbul Medeniyet University | — |
| Completed | Use of Alternative Therapy in Acne Vulgaris Patients NCT04538729 | Istanbul Medeniyet University | — |
| Unknown | Evaluation of the Presence of Enthesitis in Patients With Acne Vulgaris NCT04224597 | Erol Olcok Corum Training and Research Hospital | — |
| Completed | Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris NCT04214652 | Bausch Health Americas, Inc. | Phase 3 |
| Completed | Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris NCT04214639 | Bausch Health Americas, Inc. | Phase 3 |
| Unknown | Efficacy and Antimicrobial Activity of Platelet Rich Plasma (PRP) in Acne Vulgaris NCT03859843 | Assiut University | Phase 3 |
| Completed | Adverse Effects of ALA-PDT for the Treatment of Moderate to Severe Acne Vulgaris: a Prospective Study NCT04709289 | Shanghai Dermatology Hospital | N/A |
| Completed | A Study Comparing Tretinoin Cream 0.025% and RETIN-A® Cream 0.025% in the Treatment of Acne Vulgaris NCT04724473 | Sun Pharmaceutical Industries, Inc. | EARLY_Phase 1 |
| Unknown | Trial of Single Microneedle Radiofrequency for Moderate-to-Severe Acne Vulgaris NCT04213638 | Xiangya Hospital of Central South University | N/A |
| Withdrawn | Acne Scarring in Skin of Color: Laser vs Microneedling NCT03395678 | Boston University | N/A |
| Completed | DMT310-003 Topical in the Treatment of Acne Vulgaris NCT04106778 | Dermata Therapeutics | Phase 2 |
| Completed | Decreasing Severity of Acne Vulgaris After the Use of a Combination of Anti-Acne Cream NCT04118296 | Sukma Skin Treatment | Phase 1 / Phase 2 |
| Unknown | Role of Vitamin D and Its Topical Analogues in Pathogenesis and Treatment of Acne Vulgaris NCT03866447 | Assiut University | Phase 4 |
| Completed | A Study to Compare FCD105 Foam to Minocycline 3% Foam, Adapalene 0.3% Foam and Vehicle Foam. NCT04104685 | Vyne Therapeutics Inc. | Phase 2 |
| Completed | Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris NCT04321070 | Sun Pharmaceutical Industries, Inc. | Phase 1 |
| Completed | Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris NCT04015375 | Torrent Pharmaceuticals Limited | Phase 3 |
| Completed | A Study on Safety and Preliminary Efficacy of ALA in Acne Vulgaris NCT04018885 | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | Phase 1 / Phase 2 |
| Completed | MUSE Study to Evaluate the Pharmacokinetics, Safety and Tolerability of S6G5T-3 NCT04059523 | Sol-Gel Technologies, Ltd. | Phase 1 |
| Completed | Moisturizer Containing Licochalcone A, Decanediol, L-carnitine and Salicylic Acid in Reducing Relapsing of Acn NCT04002024 | Mahidol University | N/A |
| Completed | Skin Acceptance and Efficacy Assessment of a Topical Product in Acne Treatment When Compared to a Placebo. NCT04216160 | YUN NV | N/A |
| Unknown | Sexual Dysfunction in Female Patients With Adult Acne Vulgaris NCT03879369 | Assiut University | — |
| Unknown | Efficacy and Safety Study of VB-1953 Topical Gel for Inflammatory Facial Acne Vulgaris NCT03900676 | Vyome Therapeutics Inc. | Phase 2 |
| Completed | Aczone Gel 7.5% in the Treatment of Acne Vulgaris in Patients With Skin of Color NCT03681470 | Icahn School of Medicine at Mount Sinai | Phase 4 |
| Completed | Participant Reported Outcomes With Use of Trifarotene 50 μg/g Cream in the Treatment of Moderate Facial and Tr NCT03915860 | Galderma R&D | Phase 3 |
| Completed | Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris NCT04134273 | Sun Pharmaceutical Industries, Inc. | Phase 1 |
| Completed | Assess the Effects and the Tolerance of Cosmetic Product in the Follow-up Phase of Facial Acne for 1 Year NCT04301063 | Pierre Fabre Dermo Cosmetique | — |
| Terminated | Evaluation of Topical Application of BMX-010 in Subjects With Acne Vulgaris. NCT03752242 | BioMimetix JV, LLC | Phase 2 |
| Unknown | Sebacia Postmarket Study of Real-World Use NCT03818555 | Sebacia, Inc. | N/A |
| Completed | A Study of S6G5T-3 in the Treatment of Acne Vulgaris NCT03761784 | Sol-Gel Technologies, Ltd. | Phase 3 |
| Completed | Effects of Oral Zinc Gluconate Among Acne Vulgaris Patients NCT05096312 | East Avenue Medical Center, Philippines | Phase 4 |
| Completed | A Study of S6G5T3 in the Treatment of Acne Vulgaris NCT03761810 | Sol-Gel Technologies, Ltd. | Phase 3 |
| Completed | Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgar NCT03664752 | Bausch Health Americas, Inc. | Phase 3 |
| Completed | Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgar NCT03664739 | Bausch Health Americas, Inc. | Phase 3 |
| Unknown | Thyroid Dysfunction in Female Patients With Acne Vulgaris: [ Relation to Other Variables ] NCT03602534 | Assiut University | — |
| Completed | A Study Comparing Two Topicals in the Treatment of Acne Vulgaris NCT03743038 | Vyne Therapeutics Inc. | Phase 1 |
| Completed | Conventional Photodynamic Therapy Versus Daylight Photodynamic Therapy for The Treatment of Acne Vulgaris NCT04631250 | Tel-Aviv Sourasky Medical Center | N/A |
| Completed | A Study of the Safety, Engraftment, and Action of Multi-Dosed NB01 in Adults With Moderate Acne NCT03709654 | Naked Biome, Inc. | Phase 1 |
| Completed | Bioequivalence Study of Clindamycin Phosphate Topical Lotion, 1% in Subjects With Acne Vulgaris NCT03717506 | Balmoral Medical company | Phase 3 |
| Completed | Comparison of Malassezia Spp Proportions in Inflammatory and Non Inflammatory Facial Acne Vulgaris Lesions NCT04367584 | Indonesia University | — |
| Completed | Bioequivalence Study of Adapalene Gel 0.3% in Subjects With Facial Acne Vulgaris NCT03650361 | Aleor Dermaceuticals Limited | Phase 3 |
| Completed | A Study to Evaluate the Efficacy and Safety of Adapalene-Clindamycin Combination Gel in the Treatment of Acne NCT03615768 | Lee's Pharmaceutical Limited | Phase 3 |
| Completed | Open-Label, Randomized Study Evaluating the Absorption and Systemic Pharmacokinetics of Topically Applied IDP- NCT03653403 | Bausch Health Americas, Inc. | Phase 1 |
| Completed | Gene Polymorphisms, Skin Barrier, and Inflammation in Acne NCT07069075 | Hong Zhang | — |
| Withdrawn | Treatment of Acne Scars With Erbium:Yttrium Aluminum Garnet (Er:YAG) Laser Examined Under OCT NCT03333759 | University of Miami | N/A |
| Completed | A Pilot Study to Evaluate the Effect of a Probiotic Mixture in Acne NCT03878238 | Bionou Research, S.L. | N/A |
| Completed | Treatment of Acne Vulgaris Using NAFL in Combination With Isotretinoin and Pricking Blood Therapy NCT04156815 | xjpfW | N/A |
| Completed | Evaluation of BTX 1503 in Patients With Moderate to Severe Acne Vulgaris NCT03573518 | Botanix Pharmaceuticals | Phase 2 |
| Terminated | The Functional and Emotional Benefits of Replenix Power of Three With Resveratrol NCT03563365 | Yardley Dermatology Associates | Phase 4 |
| Completed | DMT310-001 Topical in the Treatment of Acne Vulgaris NCT03536637 | Dermata Therapeutics | Phase 2 |
| Unknown | Apelin12 in Acne Vulgaris NCT03480503 | Assiut University | — |
| Completed | Bioequivalence Study of Clindamycin Gel 1% in Treatment of Acne Vulgaris NCT03522441 | Akorn, Inc. | Phase 3 |
| Completed | The Efficacy of an Oral Probiotic Associated With a Fixed Combination of Benzoyl Peroxide and Adapalene in the NCT05216289 | Federal University of São Paulo | Phase 4 |
| Recruiting | Anti-inflammatory Effects of Topical Erythromycin and Clindamycin in Acne Patients NCT03883269 | Centre for Human Drug Research, Netherlands | Phase 4 |
| Completed | Randomized Double-blind Study on the Benefit of Spironolactone for Treating Acne of Adult Woman. NCT03334682 | Nantes University Hospital | Phase 3 |
| Completed | A Study of the Safety, Engraftment, and Action of NB01 in Adults With Moderate Acne NCT03450369 | Naked Biome, Inc. | Phase 1 |
| Completed | Acne Remission Maintenance by Weekend Systemic Isotretinoin NCT06451237 | Alexandria University | Phase 3 |
| Completed | Acne Vulgaris Related Microbiology and Serology NCT04056598 | Sanofi | — |
| Completed | Multimodal Optical Imaging for Pretreatment Evaluation for Cutaneous Microparticle Delivery NCT03573115 | Merete Haedersdal | N/A |
| Unknown | Polymorphism of Extrapituitary Promoter of PRL Gene and Relationships With Serum Prolactin Levels in Acne Vulg NCT03186222 | Assiut University | — |
| Completed | Bioequivalence Study of Two Treatments in the Treatment of Acne Vulgaris on the Face NCT03393494 | Padagis LLC | Phase 3 |
| Completed | Relationship of Whole Blood Zinc Levels to Acne Severity NCT04975412 | East Avenue Medical Center, Philippines | — |
| Unknown | Combined Treatment With CO2 Laser and Isotretinoin for Acne Scars NCT04870489 | Tel-Aviv Sourasky Medical Center | Phase 2 |
| Completed | A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study in the Tr NCT03170388 | Bausch Health Americas, Inc. | Phase 2 |
| Completed | A Phase 2 Safety and Efficacy Study of UHE-101 Cream in Subjects With Acne Vulgaris NCT03307577 | Therapeutics, Inc. | Phase 2 |
| Completed | A Bioavailability Study of DFD-03 Compared to Tazorac® in Patients With Moderate Acne Vulgaris NCT03599193 | Dr. Reddy's Laboratories Limited | Phase 2 |
| Completed | Non-Significant Risk Study of Sebacia Microparticles in the Treatment of Facial Acne Vulgaris NCT03303170 | Sebacia, Inc. | N/A |
| Unknown | Efficacy of Acupuncture Combined With Moving Cupping and Ear Point Tapping for Moderate and Severe Acne Vulgar NCT03264287 | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | N/A |
| Completed | To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.1% and RLD in the Treatment of Acne V NCT03427554 | Sun Pharmaceutical Industries, Inc. | EARLY_Phase 1 |
| Completed | A Study to Assess the Safety and Local Tolerability of DFD-03 (Tazarotene) Lotion, 0.1% Compared to Tazorac® C NCT03341910 | Dr. Reddy's Laboratories Limited | Phase 2 |
| Completed | To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.05% and RLD in the Treatment of Acne NCT03433378 | Sun Pharmaceutical Industries, Inc. | EARLY_Phase 1 |
| Completed | A Study of the Safety and Efficacy of DFD-03 for the Treatment of Acne Vulgaris NCT03290027 | Dr. Reddy's Laboratories Limited | Phase 3 |
| Completed | The Use of Onexton in Moderate Acne Vulgaris for Patients With Skin of Color NCT03402893 | Derm Research, PLLC | Phase 4 |
| Completed | A Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 in the Treatment of Moderate-t NCT03271021 | Vyne Therapeutics Inc. | Phase 3 |
| Completed | A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (3 NCT03168334 | Bausch Health Americas, Inc. | Phase 3 |
| Completed | A Study of the Safety and Efficacy of DFD-03 Lotion in the Treatment of Acne Vulgaris for 12 Weeks NCT03292640 | Dr. Reddy's Laboratories Limited | Phase 3 |
| Completed | A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (3 NCT03168321 | Bausch Health Americas, Inc. | Phase 3 |
| Completed | Correlation Between Dehydroepiandrosterone Sulfate and Sebum Level in Adult Female Acne Vulgaris NCT04555018 | Dr.dr.Irma Bernadette, SpKK (K) | — |
| Completed | Erbium-YAG Laser Versus Platelet Rich Plasma in the Treatment of Atrophic Acne Scars NCT03933033 | Aswan University Hospital | N/A |
| Completed | A Study to Evaluate the Tolerance of an Acne Treatment in Sensitive Skin Subjects With Mild to Moderate Acne V NCT03128723 | Johnson & Johnson Consumer Inc. (J&JCI) | N/A |
| Completed | A Study to Evaluate the Efficacy and Tolerance of 2 Acne Treatment Regimens on Subjects With Mild to Moderate NCT03124381 | Johnson & Johnson Consumer Inc. (J&JCI) | N/A |
| Terminated | Six Months Evaluation of Next Science Acne Creams on Facial Acne in Adult Females. NCT03106766 | Next Science TM | EARLY_Phase 1 |
| Completed | A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris NCT03127956 | Dermira, Inc. | Phase 3 |
| Completed | Open Label Photo-Documentation Study Of BPX-01 Minocycline Gel NCT02946788 | BioPharmX, Inc. | Phase 2 |
| Completed | Prevalence of H.Pylori in Patients With Acne Vulgaris Acne Vulgaris NCT03411733 | Sohag University | — |
| Completed | A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris NCT03073486 | Dermira, Inc. | Phase 3 |
| Completed | Subject Reported Outcomes With Use of Adapalene 0.3% - Benzoyl Peroxide (BPO) 2.5% in Dark Skin Acne NCT02932267 | Galderma R&D | Phase 3 |
| Completed | A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris NCT03028363 | Dermira, Inc. | Phase 3 |
| Completed | Study of Efficacy and Safety of CJM112 in Patients With Moderate to Severe Inflammatory Acne NCT02998671 | Novartis Pharmaceuticals | Phase 2 |
| Completed | Imaging of Pilosebaceous Units and Acne Lesions by RCM and OCT Confocal Microscopy and Optical Coherence Tomog NCT03524040 | Merete Haedersdal | N/A |
| Completed | Safety and Efficacy Trial of ACZONE (Dapsone) Gel, 7.5% in 9 to 11 Year-Old Patients With Acne Vulgaris NCT02959970 | Almirall, S.A. | Phase 4 |
| Completed | An Evaluation of the Adrenal Suppression Potential and PK of CB-03-01 Cream in Pediatric Patients With Acne Vu NCT02720627 | Cassiopea SpA | Phase 2 |
| Completed | Efficacy Study in Patients With Acne Vulgaris. NCT02935036 | Sun Pharmaceutical Industries, Inc. | Phase 2 |
| Completed | A Study Comparing Tazarotene Cream 0.1% to TAZORAC® (Tazarotene) Cream 0.1% and Both to a Placebo Control in t NCT02886715 | Fougera Pharmaceuticals Inc. | Phase 3 |
| Terminated | Venus Versa Diamondpolar Applicator Treatment Followed by AC Dual Applicator Treatment for Facial Acne Vulgari NCT02924428 | Venus Concept | N/A |
| Completed | Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris NCT03132194 | Sun Pharmaceutical Industries, Inc. | Phase 1 |
| Completed | Clinical Trial in Subjects With Mild to Moderate Acne Vulgaris NCT02832063 | AOBiome LLC | Phase 2 / Phase 3 |
| Completed | BPX-01 Minocycline Topical Gel in the Treatment of Acne Vulgaris NCT02815332 | BioPharmX, Inc. | Phase 2 |
| Completed | Efficacy and Tolerability of Nicotinamide Plus Cream for Moderate Acne Vulgaris in Indonesia NCT03626298 | Rumah Sakit Pusat Angkatan Darat Gatot Soebroto | Phase 4 |
| Completed | Long-term Follow-up Study of Subjects Who Completed Clinical Studies 755.1100_FA, 810.1100_FA, or 1064.1100_FA NCT03039634 | Sienna Labs | — |
| Completed | A Treatment for Severe Inflammatory Acne Subjects NCT02899000 | Galderma R&D | Phase 4 |
| Completed | Pharmacokinetics of Topical SB204 in Adolescents With Acne Vulgaris NCT02801903 | Novan, Inc. | Phase 1 |
| Completed | Efficacy of Microneedling With Topical Vitamin C in Treatment of Acne Scarring NCT03522922 | Sohag University | Phase 1 / Phase 2 |
| Withdrawn | TSN2898-201 Safety and Efficacy of TSN2898 in the Treatment of Acne Vulgaris NCT02796066 | Thesan Pharmaceuticals, Inc. | Phase 2 |
| Completed | Explorative Trial Evaluating the Efficacy and Tolerability of LEO43204 in Moderate to Severe Acne NCT02575950 | LEO Pharma | Phase 2 |
| Completed | Adapalene 0.3% - Benzoyl Peroxide 2.5% Gel and Risk of Formation of Atrophic Acne Scars NCT02735421 | Galderma R&D | Phase 4 |
| Completed | P3 Long Term Safety Study of Once Daily SB204 in Acne NCT02798120 | Novan, Inc. | Phase 3 |
| Completed | Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris NCT02661958 | Sol-Gel Technologies, Ltd. | Phase 2 |
| Completed | A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-S NCT02815280 | Vyne Therapeutics Inc. | Phase 3 |
| Completed | Teledermatology and Modulation of Antibiotic Dose in Acne Vulgaris NCT02905851 | University of California, Davis | N/A |
| Completed | A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-S NCT02815267 | Vyne Therapeutics Inc. | Phase 3 |
| Unknown | Studying the Skin Microbiome and the Potential of a Topical Probiotic Cream for Patients With Acne NCT03469076 | University Hospital, Antwerp | N/A |
| Completed | BPX-01 Minocycline 1% Topical Gel for Reduction of Propionibacterium Acnes NCT02709096 | BioPharmX, Inc. | Phase 2 |
| Completed | Tazarotene Plus Clindamycin vs. Adapalene Plus Clindamycin in the Treatment of Facial Acne Vulgaris NCT02721173 | All India Institute of Medical Sciences, Bhubaneswar | Phase 4 |
| Completed | Combined Salicylic and Azaleic Acid Verus Trichloroacetic Acid 25% Peel in Treatment of Acne NCT03071549 | Cairo University | Phase 3 |
| Completed | A Study to Evaluate the Effectiveness and Tolerance of Two Acne Treatments on Subjects With Mild to Moderate A NCT02698436 | Johnson & Johnson Consumer and Personal Products Worldwide | N/A |
| Completed | An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acn NCT02682264 | Cassiopea SpA | Phase 3 |
| Completed | Timolol for the Treatment of Acne and Rosacea NCT02774590 | Johns Hopkins University | Phase 1 |
| Active Not Recruiting | Lipidome and Microbiome Profile of Acne NCT02713607 | University of California, Davis | Phase 1 / Phase 2 |
| Withdrawn | A Trial of Pulse Dyed Laser (Chromogenex Regenlite Transform) in the Treatment of Inflammatory Acne Vulgaris NCT02647528 | Sadick Research Group | Phase 4 |
| Completed | P3 Study in Acne Comparing Once Daily SB204 and Vehicle NCT02672332 | Novan, Inc. | Phase 3 |
| Completed | P3 Study Comparing Once Daily SB204 and Vehicle Gel in Acne NCT02667444 | Novan, Inc. | Phase 3 |
| Completed | Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris NCT02865005 | Seegpharm S.A. | Phase 3 |
| Completed | A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (25) NCT02608450 | Cassiopea SpA | Phase 3 |
| Completed | Low Glycemic Index and Load Diet for the Treatment of Acne NCT03585140 | Centro Dermatológico Dr. Ladislao de la Pascua | N/A |
| Completed | Efficacy and Safety of CD5789 (Trifarotene) 50μg/g Cream Versus Vehicle Cream in Acne Vulgaris NCT02566369 | Galderma R&D | Phase 3 |
| Completed | A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (26) NCT02608476 | Cassiopea SpA | Phase 3 |
| Completed | Safety and Efficacy of IDP-123 Lotion to Tazorac® Cream, in the Treatment of Acne Vulgaris NCT02938494 | Bausch Health Americas, Inc. | Phase 2 |
| Completed | Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris NCT03003247 | Bausch Health Americas, Inc. | Phase 2 |
| Completed | Double-Blind Efficacy and Safety of CD5789 (Trifarotene) 50µg/g Cream Versus Vehicle Cream in Acne Vulgaris NCT02556788 | Galderma R&D | Phase 3 |
| Completed | DUAC® Early Onset Efficacy Study in Japanese Subjects NCT02557399 | GlaxoSmithKline | Phase 4 |
| Completed | A Thorough ECG Study in Subjects With Acne Vulgaris Treated With SB204 NCT02581072 | Novan, Inc. | Phase 1 |
| Completed | A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects NCT02571998 | Maruho Co., Ltd. | Phase 2 |
| Unknown | A Study Comparing the Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris NCT02537483 | Valeant Pharmaceuticals | Phase 2 |
| Completed | A Safety and Efficacy Evaluation of Topical Treatments for Moderate-Severe Facial Acne Vulgaris NCT02604680 | Braintree Laboratories | Phase 2 |
| Completed | De Novo Lipogenesis of Sebaceous Glands in Acne NCT02620813 | University of California, Davis | EARLY_Phase 1 |
| Completed | A Safety, Tolerability, Efficacy and Exposure Study of XEN801 Topical Gel NCT02656043 | Xenon Pharmaceuticals Inc. | Phase 1 / Phase 2 |
| Unknown | Study to Compare the Safety and Efficacy of IDP-123 Lotion to Tazorac Cream in the Treatment of Acne Vulgaris NCT02525822 | Valeant Pharmaceuticals | Phase 2 |
| Unknown | A Study Comparing the Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulga NCT02535871 | Valeant Pharmaceuticals | Phase 3 |
| Unknown | A Study Comparing the Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulga NCT02491060 | Valeant Pharmaceuticals | Phase 3 |
| Completed | Study Comparing Adapalene/BP Gel to EPIDUO® FORTE and Both to a Placebo Control in Treatment of Acne Vulgaris NCT02709902 | Sun Pharmaceutical Industries, Inc. | Phase 1 |
| Completed | A Double Blind, Placebo-Controlled, Randomized Study in Subjects With Acne Vulgaris NCT02656485 | AOBiome LLC | Phase 1 / Phase 2 |
| Completed | Benzac 5% Gel in Combination With Cosmetic Products in Acne Vulgaris NCT02589405 | Galderma R&D | Phase 4 |